Table 1.
Baseline information of patients included in this study
| Characteristics | Overall (n = 354) | Survivor (n = 232) | Non-survivor (n = 122) | P value |
|---|---|---|---|---|
| NRBC, % | 1 (1, 2) | 1 (1, 2) | 1 (1, 3) | < 0.001 |
| Sex, n (%) | 0.330 | |||
| Female | 150 (42.4%) | 94 (40.5%) | 56 (45.9%) | |
| Male | 204 (57.6%) | 138 (59.5%) | 66 (54.1%) | |
| Race, n (%) | 0.857 | |||
| White | 217 (61.3%) | 143 (61.6%) | 74 (60.7%) | |
| Non-white | 137 (38.7%) | 89 (38.4%) | 48 (39.3%) | |
| Age, n (%) | 57 (46, 70) | 52 (42, 65) | 67 (52, 78) | < 0.001 |
| <60 | 192 (54.2%) | 146 (62.9%) | 46 (37.7%) | |
| ≥60 | 162 (45.8%) | 86 (37.1%) | 76 (62.3%) | |
| MAP, mmHg | 77 (56, 100) | 79 (58, 104) | 71 (52, 95) | 0.016 |
| Critical Care Score | ||||
| SOFA | 9 (5, 12) | 8 (5, 11) | 10 (7, 13) | < 0.001 |
| SAPSII | 44 (33, 55) | 40 (28.75, 53.25) | 50 (41, 58.75) | < 0.001 |
| OASIS | 39 (31, 46) | 37 (30, 44) | 42 (34, 48) | < 0.001 |
| LODS | 7 (4.25, 10) | 6 (4, 9) | 8 (6, 11) | < 0.001 |
| APSIII | 68.5 (49, 90) | 62 (44, 84) | 78 (63, 101.75) | < 0.001 |
| GCS | 9 (3, 14) | 14 (9, 15) | 13 (9, 15) | 0.417 |
| Co-morbidity | ||||
| Diabetes, n (%) | 100 (28.2%) | 64 (27.6%) | 36 (29.5%) | 0.703 |
| CHF, n (%) | 93 (26.3%) | 49 (21.1%) | 44 (36.1%) | 0.002 |
| CPD, n (%) | 69 (19.5%) | 42 (18.1%) | 27 (22.1%) | 0.363 |
| Renal disease, n (%) | 69 (19.5%) | 36 (15.5%) | 33 (27.0%) | 0.009 |
| Cerebrovascular disease, n (%) | 30 (8.5%) | 22 (9.5%) | 8 (6.6%) | 0.348 |
| Treatment | ||||
| Vasopressin, n (%) | 116 (32.8%) | 54 (23.3%) | 62 (50.8%) | < 0.001 |
| Norepinephrine, n (%) | 183 (51.7%) | 100 (43.1%) | 83 (68%) | < 0.001 |
| RRT, n (%) | 29 (8.2%) | 17 (7.3%) | 12 (9.8%) | 0.413 |
Abbreviations: APS III, Acute Physiology Score III; CHF, Congestive Heart Failure; CPD, Chronic Pulmonary Disease; GCS, Glasgow Coma Scale; LODS, Logistic Organ Dysfunction System; MAP, Mean Arterial Pressure; NRBC, Nucleated Red blood Cells; OASIS, Oxford Acute Severity of Illness Score; RRT, renal replacement therapy; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment